期刊文献+

肠溶阿司匹林和肝素联合抗凝治疗中出现腹膜后血肿

Retroperitoneal hematoma occurring during anticoagulant therapy with enteric-coated aspirin plus heparin
原文传递
导出
摘要 1例69岁冠心病、高血压女性患者服用卡托普利、阿替洛尔、硝酸异山梨酯及硝苯地平治疗2年余。入院后,患者因不稳定心绞痛加用肠溶阿司匹林0.1 g,1次/d和低分子肝素钙5 000 U,1次/12 h皮下注射。第2天,肠溶阿司匹林增加至0.3 g,1次/d;低分子肝素钙改为肝素钠800~1 500 U/h,静脉泵入。48 h后再次改为低分子肝素钙6 000 U,1次/12 h皮下注射。第5天,患者出现腹膜后血肿,出血量约1 000~1 200 ml。停用肠溶阿司匹林和低分子肝素钙,给予悬浮红细胞、巴曲酶及扩容治疗。入院第28天,CT检查示患者血肿有所吸收,2 d后出院。出院2个月CT复查示出血肿大部分吸收。 A 69-year-old woman with coronary heart disease and hypertension received captopril, atenolol, isosorbide dinitrate, and nifedipine for two years and more. After admission, enteric-coated aspirin 0.1 g once daily and SC low molecular weight heparin calaium 5 000 U once every 12 hours were added to her regimen due to unstable angina. The next day, her enteric-coated aspirin dosage was increased to 0.3 g once daily, and low molecular weight beparin calcium was changed to heparin sodium 800-1 500 U/h, which was administered via an intraveous infusion pump. Forty-eight hours later, heparin sodium was switched to SC low molecular weight heparin calcium 6 000 U once every 12 hours again. On day 5, the patient developed retroperitoneal he matoma, and the amount of bleeding was 1 000-1 200 ml. Enteric-coated aspirin and low molecular weight heparin calcium were withdrawn. RBC suspension, batroxobin, and fluid expansion were given. On day 28 after hospitalization, a CT scan revealed that his hematoma was absorbed in some degree and she was discharged two days later. Two months after discharge, repeated CT scan showed that a greater part of hematoma was absorbed.
作者 王艳辉
出处 《药物不良反应杂志》 2009年第3期215-217,共3页 Adverse Drug Reactions Journal
关键词 抗凝治疗 肠溶阿司匹林 低分子肝素钙 肝素钠 不良反应 腹膜后血肿 anticoagulant treatment enteric-coated aspirin low molecular weight heparin calcium heparin sodium adverse reactions retroperitoneal hematoma
  • 相关文献

参考文献7

二级参考文献18

  • 1史陈让.创伤性腹膜后血肿的诊治[J].中国实用外科杂志,1995,15(11):651-652. 被引量:61
  • 2桑秀文.低分子肝素注射方法与注射部位的观察[J].吉林医学,2005,26(9):976-976. 被引量:7
  • 3庄芳,刘玉洁,肖玉荣.低分子肝素不同注射部位的探讨[J].家庭护士,2006(01X):33-34. 被引量:11
  • 4耿洪业 宋文宣 李扬 等.实用内科药物治疗学[M].北京:人民卫生出版社,2000.323-324.
  • 5The Columbus investigators. Low molecular weight heparin in the treatment of patient with venous thromboembolism[J].N Engl J Med, 1997,337:657-662.
  • 6FRAX IS.Fraxiparin vs unfraactionated heparin[J].Am Heart J,1999,137:180-186.
  • 7Gurfinkel EP,Manos EJ,Mejail RI,et al.Low molecular weight heparin on aspirin in the treatment of unstable angina and silent ischemia[J].J Am Coll Cardiol,1995,26(2):313-318.
  • 8MALIK A, CAPLING R, BASTANI B. Enoxaparin-associated retroperitoneal bleeding in two patients with renal insufficiency [J]. Pharmacotherapy, 2005, 25 (5): 769-772.
  • 9DABNEY A, BASTANI B. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases[J]. Intensive Care Med, 2001, 27 (12): 1954-1957.
  • 10MELDE S L. Enoxaparin-induced retroperitoneal hematoma [J]. Ann Pharmacother, 2003, 37 (6): 822-824.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部